EcoDrugPlus

Insulin-Like Growth Factor 1b Receptor

Ensembl ID : ENSOJAG00000012573
Gene Symbol: IGF1RB
1 Cross references
203 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSOJAG00000006028
Gene Symbol: ITGB3A
1 Cross references
201 Possible Orthologues:

Integrin Beta 3b

Ensembl ID : ENSOJAG00000016087
Gene Symbol: ITGB3B
1 Cross references
194 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSOJAG00000017034
Gene Symbol: ITGA4
1 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSOJAG00000019542
Gene Symbol: ITGA5
1 Cross references
197 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSOJAG00000009281
Gene Symbol: ITGB6
1 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSOJAG00000014971
Gene Symbol: ITGB8
1 Cross references
202 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSOJAG00000002281
Gene Symbol: ITGA5
1 Cross references
206 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSOJAG00000009577
Gene Symbol: ITGAV
1 Cross references
237 Possible Orthologues:

Integrin, Beta 1a

Ensembl ID : ENSOJAG00000016103
Gene Symbol: ITGB1A
1 Cross references
214 Possible Orthologues:

Integrin, Beta 1b.1

Ensembl ID : ENSOJAG00000015398
Gene Symbol: ITGB1B.1
1 Cross references
228 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSOJAG00000016172
Gene Symbol: ITGB5
1 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).